[Treatment of rheumatic diseases with immunosuppressive substances].
D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010396:Penicillamine / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D010396:Penicillamine
Die Behandlung rheumatischer Erkrankungen mit immunsuppressiven Substanzen.